6d
Medpage Today on MSNMobile 'Man Van' Shows Promise for Reaching High-Risk Prostate Cancer GroupsThe "Man Van" reached almost 3,500 men, 85% of whom showed up for scheduled screening exams. Almost 100 prostate cancers were ...
A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...
A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...
Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.
First of all, you know we have a very mixed audience, so can you just level set for us and speak about the population you studied in this important trial - that low risk, favorable, intermediate risk ...
Adults 45 and older should start routine colorectal cancer screenings. People at higher risk due to family history or other ...
A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...
Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...
Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...
6d
News Medical on MSNGlobally prostate and testicular cancer rates climb, but mortality is fallingNew research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...
PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results